This appears to be a commentary or perspective piece in The Lancet Infectious Diseases discussing the broader value of RSV (respiratory syncytial virus) prevention beyond direct clinical outcomes.
Only a DOI and title are available; full text was not provided, so specific findings, populations, or data cannot be extracted.
